Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction

Health Canada carried out a safety review after learning that the European Medicines Agency was looking into a potential interaction between levetiracetam and methotrexate. The interaction between the two drugs may lead to higher amount of methotrexate in the blood, which may cause serious side effects. The side effects, which can be fatal, include sudden (acute) kidney failure.

Données et ressources

Info additionnelle

Champ Valeur
Dernière modification janvier 16, 2026, 20:39 (TU)
Créé le janvier 16, 2026, 20:39 (TU)
contains_pii non
crisis_categories Canicules
criticality_level Faible
data_formats HTML
fair_openness Level 2 - Machine-readable
geographic_scope Canada
sensitivity_level Faible
source_inventaire Inventaire_W
source_url https://open.canada.ca/data/en/dataset/15a5bf9a-b1e2-4e61-8515-e68598682b61
subject health_and_safety
update_frequency as_needed
year_most_recent 2024-05-09 14:31:26.729000
year_start 2024-05-07 14:42:00.393000